Pharmacological Therapy of Osteoporosis: What’s New?
Giovanni Iolascon,1 Antimo Moretti,1 Giuseppe Toro,1 Francesca Gimigliano,2 Sara Liguori,1 Marco Paoletta1 1Department of Medical and Surgical Specialties and Dentistry, University of Campania “Luigi Vanvitelli”, Naples, Italy; 2Department of Physical and Mental Health and Preven...
Guardado en:
Autores principales: | Iolascon G, Moretti A, Toro G, Gimigliano F, Liguori S, Paoletta M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/eb227d0a591949e9b37547517b7ed9c1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Abaloparatide and the Spine: A Narrative Review
por: Thompson JC, et al.
Publicado: (2020) -
Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals
por: Felicia Cosman, et al.
Publicado: (2021) -
Pharmacological treatment of osteoporosis in the oldest old
por: Vandenbroucke A, et al.
Publicado: (2017) -
Tai chi for treating osteopenia and primary osteoporosis: a meta-analysis and trial sequential analysis
por: Zhang YL, et al.
Publicado: (2019) -
Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats
por: Chin KY, et al.
Publicado: (2014)